Cesca Therapeutics Inc. (KOOL) Reaches $0.50 52 Week Low; Federated Investors Lifted Its Noble Plc (NE) Stake

May 18, 2018 - By Marguerite Chambers

Cesca Therapeutics Inc. (NASDAQ:KOOL) Logo

Federated Investors Inc increased Noble Corp Plc (NE) stake by 90.7% reported in 2017Q4 SEC filing. Federated Investors Inc acquired 540,659 shares as Noble Corp Plc (NE)’s stock declined 13.24%. The Federated Investors Inc holds 1.14M shares with $5.14M value, up from 596,091 last quarter. Noble Corp Plc now has $1.45 billion valuation. The stock increased 0.34% or $0.02 during the last trading session, reaching $5.87. About 1.96 million shares traded. Noble Corporation plc (NYSE:NE) has declined 36.28% since May 18, 2017 and is downtrending. It has underperformed by 47.83% the S&P500.

The stock of Cesca Therapeutics Inc. (NASDAQ:KOOL) hit a new 52-week low and has $0.46 target or 9.00% below today’s $0.50 share price. The 9 months bearish chart indicates high risk for the $5.75 million company. The 1-year low was reported on May, 18 by Barchart.com. If the $0.46 price target is reached, the company will be worth $517,860 less. The stock decreased 5.45% or $0.0289 during the last trading session, reaching $0.5011. About 492,857 shares traded or 98.36% up from the average. Cesca Therapeutics Inc. (NASDAQ:KOOL) has declined 36.51% since May 18, 2017 and is downtrending. It has underperformed by 48.06% the S&P500.

Among 2 analysts covering Cesca Therapeutics (NASDAQ:KOOL), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Cesca Therapeutics had 4 analyst reports since August 25, 2015 according to SRatingsIntel. The company was maintained on Tuesday, November 17 by Maxim Group. Zacks upgraded the shares of KOOL in report on Tuesday, August 25 to “Sell” rating. The rating was upgraded by H.C. Wainwright on Monday, September 21 to “Buy”. Maxim Group downgraded Cesca Therapeutics Inc. (NASDAQ:KOOL) on Tuesday, December 22 to “Hold” rating.

More notable recent Cesca Therapeutics Inc. (NASDAQ:KOOL) news were published by: Globenewswire.com which released: “Cesca Announces Closing of $5.5 Million Public Offering” on May 18, 2018, also Streetinsider.com with their article: “Cesca Therapeutics (KOOL) Prices $5.5 Million Public Offering of Common Stock, Warrants” published on May 16, 2018, Nasdaq.com published: “Mid-Afternoon Market Update: Netshoes Drops Following Q1 Results; Red Violet Shares Surge” on May 15, 2018. More interesting news about Cesca Therapeutics Inc. (NASDAQ:KOOL) were released by: Seekingalpha.com and their article: “Cesca Therapeutics Inc. (KOOL) Q1 2018 Results – Earnings Call Transcript” published on May 15, 2018 as well as Benzinga.com‘s news article titled: “Benzinga’s Daily Biotech Pulse: ASCO Abstracts, Fibrocell, Ispen And More” with publication date: May 17, 2018.

Cesca Therapeutics Inc. focuses on the research, development, and commercialization of autologous cell therapeutics for use in regenerative medicine in the United States and internationally. The company has market cap of $5.75 million. The firm develops and makes automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. It currently has negative earnings. The Company’s products include SurgWerks system, a proprietary system comprised of the SurgWerks processing platform, including devices and analytics, and indication-specific SurgWerks procedure kits for use in regenerative stem cell therapy at the point of care for vascular and orthopedic diseases; CellWerks system, a proprietary cell processing system with associated analytics for intra-laboratory preparation of adult stem cells from bone marrow or blood; and AutoXpress system, a proprietary automated device and companion sterile disposable for concentrating hematopoietic stem cells from cord blood.

Investors sentiment increased to 1.02 in 2017 Q4. Its up 0.24, from 0.78 in 2017Q3. It is positive, as 33 investors sold NE shares while 68 reduced holdings. 40 funds opened positions while 63 raised stakes. 209.10 million shares or 1.03% less from 211.28 million shares in 2017Q3 were reported. Bnp Paribas Asset Management Holding Sa reported 0.02% in Noble Corporation plc (NYSE:NE). New York State Common Retirement Fund reported 0.01% in Noble Corporation plc (NYSE:NE). Gsa Cap Prtnrs Ltd Liability Partnership holds 0.01% in Noble Corporation plc (NYSE:NE) or 33,394 shares. 167 were accumulated by Private Ocean Ltd Liability Company. Moreover, Guardian Life Insur Com Of America has 0% invested in Noble Corporation plc (NYSE:NE) for 2 shares. Jfs Wealth Advisors Ltd Liability owns 7,855 shares. Captrust holds 0% or 125 shares. Monroe Bancorporation And Trust Mi invested in 0% or 800 shares. Pacific Glob Invest Communications owns 642,224 shares for 0.63% of their portfolio. Indexiq Advsr Ltd has invested 0% in Noble Corporation plc (NYSE:NE). 67,784 were accumulated by Tudor Et Al. Zurcher Kantonalbank (Zurich Cantonalbank) invested 0% of its portfolio in Noble Corporation plc (NYSE:NE). Ls Advisors Limited Liability Corporation reported 6,852 shares. Northern Trust Corporation reported 3.23 million shares or 0% of all its holdings. Capstone Inv Advisors Ltd invested 0.01% in Noble Corporation plc (NYSE:NE).

Federated Investors Inc decreased Lakeland Finl Corp (NASDAQ:LKFN) stake by 11,173 shares to 14,988 valued at $727,000 in 2017Q4. It also reduced Cooper Tire & Rubr Co (NYSE:CTB) stake by 68,093 shares and now owns 32,367 shares. Tivity Health Inc was reduced too.

Among 34 analysts covering Noble Corp PLC (NYSE:NE), 10 have Buy rating, 8 Sell and 16 Hold. Therefore 29% are positive. Noble Corp PLC had 101 analyst reports since July 31, 2015 according to SRatingsIntel. Piper Jaffray maintained Noble Corporation plc (NYSE:NE) rating on Thursday, October 19. Piper Jaffray has “Hold” rating and $2.85 target. The firm has “Neutral” rating given on Wednesday, September 21 by Goldman Sachs. The stock of Noble Corporation plc (NYSE:NE) earned “Buy” rating by Societe Generale on Tuesday, February 14. RBC Capital Markets maintained the stock with “Sector Perform” rating in Friday, March 11 report. Credit Suisse maintained the shares of NE in report on Monday, April 24 with “Buy” rating. The company was maintained on Monday, February 26 by Piper Jaffray. The firm earned “Sector Perform” rating on Wednesday, September 14 by Howard Weil. The rating was maintained by Seaport Global on Monday, February 26 with “Hold”. On Thursday, July 20 the stock rating was maintained by RBC Capital Markets with “Sell”. Citigroup maintained it with “Neutral” rating and $11 target in Wednesday, March 16 report.

Noble Corporation plc (NYSE:NE) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.